Steven G Deeks Selected Research

HIV Antibodies

1/2018	Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir?
1/2017	HIV Antibody Level as a Marker of HIV Persistence and Low-Level Viral Replication.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven G Deeks Research Topics

Disease

85	HIV Infections (HIV Infection) 06/2022 - 06/2002
69	Infections 10/2022 - 08/2003
46	Viremia 01/2022 - 01/2002
38	Inflammation (Inflammations) 01/2022 - 12/2006
33	Acquired Immunodeficiency Syndrome (AIDS) 10/2021 - 01/2007
17	Disease Progression 01/2020 - 12/2003
12	COVID-19 10/2022 - 01/2021
9	Neoplasms (Cancer) 01/2022 - 09/2012
8	Atherosclerosis 01/2020 - 06/2009
7	Persistent Infection 01/2022 - 06/2006
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 03/2011
4	Hypertension (High Blood Pressure) 10/2020 - 04/2004
4	Lymphoma (Lymphomas) 01/2018 - 08/2013
4	Virus Diseases (Viral Diseases) 04/2017 - 12/2010
4	Chronic Disease (Chronic Diseases) 12/2016 - 07/2010
3	Latent Infection 01/2020 - 01/2016
3	Carotid Artery Diseases 01/2020 - 02/2011
3	Fibrosis (Cirrhosis) 01/2017 - 10/2011
3	Coinfection 12/2016 - 09/2009
2	Post-Acute COVID-19 Syndrome 01/2022 - 01/2022
2	Communicable Diseases (Infectious Diseases) 12/2021 - 01/2016
2	Fever (Fevers) 07/2021 - 03/2021
2	Cough 07/2021 - 03/2021
2	Arteritis 01/2021 - 01/2017
2	Myocardial Infarction 01/2019 - 09/2009
2	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2017 - 02/2012
2	Pulmonary Arterial Hypertension 01/2016 - 02/2014
2	Hepatitis B 07/2014 - 07/2014
2	Proteinuria 06/2014 - 04/2012
2	Chronic Renal Insufficiency 06/2014 - 04/2012
2	Crohn Disease (Crohn's Disease) 12/2013 - 04/2013
2	Hepatitis C 11/2013 - 07/2011
2	Kidney Diseases (Kidney Disease) 04/2012 - 06/2011
2	Opportunistic Infections (Opportunistic Infection) 04/2012 - 11/2011

Drug/Important Bio-Agent (IBA)

56	RNA (Ribonucleic Acid)IBA 10/2022 - 02/2002
17	Biomarkers (Surrogate Marker)IBA 06/2022 - 04/2010
16	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 03/2011
15	Pharmaceutical PreparationsIBA 01/2020 - 02/2002
10	CytokinesIBA 01/2021 - 11/2005
10	Interleukin-6 (Interleukin 6)IBA 01/2021 - 04/2012
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2010
9	fibrin fragment D (D-dimer)IBA 12/2016 - 04/2012
8	Antiviral Agents (Antivirals)IBA 01/2022 - 06/2002
8	Lipopolysaccharide ReceptorsIBA 12/2016 - 03/2011
7	Peptides (Polypeptides)IBA 10/2021 - 12/2010
6	AntibodiesIBA 01/2022 - 01/2014
6	AntigensIBA 01/2021 - 03/2004
6	C-Reactive ProteinIBA 01/2021 - 04/2012
5	Biological ProductsIBA 01/2022 - 07/2012
5	Tryptophan (L-Tryptophan)FDA Link 01/2022 - 02/2013
5	InterferonsIBA 10/2021 - 04/2007
5	Immunoglobulin G (IgG)IBA 03/2021 - 06/2012
5	Protease Inhibitors (Protease Inhibitor)IBA 02/2017 - 08/2003
5	HLA-DR Antigens (HLA-DR)IBA 04/2011 - 03/2006
4	VaccinesIBA 01/2022 - 01/2011
4	Messenger RNA (mRNA)IBA 08/2021 - 01/2014
3	Viral ProteinsIBA 01/2020 - 08/2017
3	Interferon-gamma (Interferon, gamma)IBA 12/2017 - 09/2009
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2017 - 07/2014
3	Immunoglobulins (Immunoglobulin)IBA 01/2017 - 07/2014
3	LipopolysaccharidesIBA 11/2014 - 01/2008
3	KynurenineIBA 10/2014 - 07/2013
3	Tenofovir (Viread)FDA Link 06/2014 - 06/2011
3	HLA-C Antigens (HLA-C)IBA 12/2013 - 12/2009
3	abacavir (Ziagen)FDA Link 11/2012 - 09/2009
2	Nucleic AcidsIBA 10/2022 - 03/2021
2	Clostridium perfringens epsilon-toxinIBA 06/2022 - 06/2022
2	Broadly Neutralizing AntibodiesIBA 01/2022 - 01/2019
2	Oxygen (Dioxygen)IBA 07/2021 - 03/2021
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 01/2020
2	LDL Lipoproteins (beta Lipoproteins)IBA 10/2020 - 11/2014
2	Indicators and Reagents (Reagents)IBA 02/2020 - 03/2012
2	EpitopesIBA 01/2020 - 01/2020
2	HLA-B57 antigenIBA 01/2020 - 11/2017
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 08/2015
2	CCR5 Receptors (CCR5 Receptor)IBA 01/2019 - 08/2015
2	Brentuximab VedotinIBA 12/2018 - 01/2018
2	HIV AntibodiesIBA 01/2018 - 01/2017
2	ChemokinesIBA 01/2018 - 01/2016
2	PerforinIBA 01/2018 - 03/2006
2	LigandsIBA 01/2017 - 02/2012
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2017 - 04/2015
2	Chemokine ReceptorsIBA 01/2016 - 04/2012
2	Disulfiram (Antabuse)FDA Link 12/2015 - 03/2014
2	pro-brain natriuretic peptide (1-76)IBA 08/2015 - 03/2011
2	MucinsIBA 04/2015 - 07/2014
2	LDL CholesterolIBA 11/2014 - 04/2004
2	Interleukin-17 (Interleukin 17)IBA 08/2014 - 05/2010
2	Glucose (Dextrose)FDA LinkGeneric 06/2014 - 02/2002
2	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 02/2014 - 07/2013
2	HLA Antigens (Human Leukocyte Antigens)IBA 11/2013 - 12/2010
2	Raltegravir Potassium FDA Link 11/2013 - 11/2012
2	EnzymesIBA 02/2013 - 07/2011

Therapy/Procedure

82	Therapeutics 01/2022 - 01/2002
31	Art Therapy 06/2022 - 11/2005
16	Highly Active Antiretroviral Therapy (HAART) 04/2015 - 06/2002
2	Immunotherapy 01/2020 - 01/2020
2	Duration of Therapy 01/2020 - 11/2005
2	Aftercare (After-Treatment) 11/2017 - 01/2004
2	Secondary Prevention 02/2016 - 09/2009